Intrathymic selection: new insight into tumor immunology

Area of Science:

• Immunology
• Cancer Research
• T cell biology

Background:

• Central tolerance in the thymus eliminates high-affinity self-reactive T cells.
• Medullary thymic epithelial cells (mTECs) uniquely express diverse tissue-specific antigens, crucial for T cell tolerance.
• Promiscuous gene expression in mTECs includes cancer immunotherapy targets like alpha-fetoprotein and gp100.

Purpose of the Study:

• To investigate how promiscuous antigen expression in the thymus impacts T cell tolerance.
• To explore strategies for overcoming tolerance to self-antigens for effective cancer immunotherapy.
• To evaluate the potential of allorestricted T cells and T cell receptor (TCR) gene therapy.

Main Methods:

• Analysis of promiscuous gene expression in medullary thymic epithelial cells (mTECs).
• Investigating the impact of self-antigen expression on T cell avidity.
• Developing a strategy using allorestricted T cells from donors for adoptive immunotherapy.

Main Results:

• Promiscuous expression of self-antigens in mTECs leads to tolerance of high-avidity cytotoxic T lymphocytes (CTLs).
• This tolerance can render tumor vaccines targeting these antigens inefficient.
• An allorestricted T cell strategy can generate high-avidity CTLs against tumor-associated antigens.

Conclusions:

• Immune tolerance to self-antigens, including tumor antigens, poses a challenge for cancer immunotherapy.
• Exploiting allorestricted T cells offers a method to circumvent tolerance and generate potent anti-tumor immunity.
• TCR gene therapy holds promise for antigen-specific immunotherapy by leveraging T cells with high avidity.